TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10838252

Group type: EXPERIMENTAL
Intervention: Passive stretching combined with the use of night splints (group A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Passive stretching (group B)
Number of subjects: 27
Study: 9235005

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg atracurium
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.075 mg/kg atracurium
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.0125 mg/kg pancuronium followed by 0.45 mg/kg atracurium
Number of subjects: 45
Study: 1540804

Group type: EXPERIMENTAL
Intervention: Duplex Doppler ultrasound measuring resistive index (RI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (children with normal renal function)
Number of subjects: 0
Study: 2434759

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29054329

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the primary motor area (M1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the supplementary motor area (SMA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All stimulation targets (M1, SMA, DLPFC)
Number of subjects: 0
Study: 27413070

Group type: EXPERIMENTAL
Intervention: Recombinant fusion protein ESAT6-CFP10 (1, 5, 10, or 20 μg/ml)
Number of subjects: 24
Study: 25715786

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous local anaesthetic infusion via wound infusion catheter (WIC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 23810678

Group type: EXPERIMENTAL
Intervention: Infliximab (standard induction and maintenance schedule)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Azathioprine (2.5 mg/kg/day)
Number of subjects: 22
Study: 20863236

Group type: EXPERIMENTAL
Intervention: Nd:YAG (1.0 W, 10 Hz, 20 sec) for dentinal tubules sealing
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Root-end cavity without Nd:YAG
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Root-end cavity and Nd:YAG application
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Root-end cavity made by Er:YAG with no focus and without Nd:YAG application
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Without root-end cavity and without Nd:YAG application
Number of subjects: 50
Study: 17962512

Group type: EXPERIMENTAL
Intervention: MIPI (MCL international prognostic index)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Cell proliferation (Ki-67)
Number of subjects: 455

Group type: COMPARATOR
Intervention: IPI and FLIPI
Number of subjects: 455
Study: 16155739

Group type: EXPERIMENTAL
Intervention: Intensive case management (ICM)
Number of subjects: 0
Study: 12852708

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 5133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5133
Study: 10377209

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 8984865

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reinforced laryngeal mask airway
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Removal of mask aperture bars
Number of subjects: 0
Study: 1658321

Group type: EXPERIMENTAL
Intervention: Menstrual pads containing sodium bicarbonate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sodium bicarbonate alone
Number of subjects: 50
Study: 6161689

Group type: EXPERIMENTAL
Intervention: SCAB chemotherapy (streptozocin, lomustine, doxorubicin hydrochloride, and bleomycin sulfate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: SCAB chemotherapy
Number of subjects: 20
Study: 30117052

Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 25

Group type: COMPARATOR
Intervention: Long pulse Nd:YAG laser
Number of subjects: 25
Study: 28833562

Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg once daily at bedtime for 13 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg
Number of subjects: 75
Study: 26237305

Group type: EXPERIMENTAL
Intervention: Water preloading (500 ml of water 30 min before meals)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Attention control (imagining stomach full before meals)
Number of subjects: 84
Study: 23319439

Group type: COMPARATOR
Intervention: Green Tea (GT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Black Tea (BT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Green Tea (GT) and Black Tea (BT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3,4-DHPAA and EGCG (in vitro treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3OMGA
Number of subjects: 0
Study: 21471566

Group type: EXPERIMENTAL
Intervention: Rituximab (1 g in 500 ml of 0.9% saline intravenously over 4 h, n=16)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline, n=8)
Number of subjects: 24
Study: 19494025

Group type: EXPERIMENTAL
Intervention: Fish oil (FO)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Olive oil (OO)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Linoleic acid (LA)
Number of subjects: 64
Study: 16424644

Group type: EXPERIMENTAL
Intervention: 6-week VACOP-B followed by high-dose sequential chemotherapy (HDS) and autologous stem cell transplantation (ASCT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 12-week VACOP-B
Number of subjects: 56
Study: 14697077

Group type: EXPERIMENTAL
Intervention: Wave-line technique
Number of subjects: 24

Group type: COMPARATOR
Intervention: Classic intravelar veloplasty
Number of subjects: 24
Study: 11402280

Group type: EXPERIMENTAL
Intervention: NSAIDs and physical therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60
Study: 9143613

Group type: EXPERIMENTAL
Intervention: HIV-positive individuals
Number of subjects: 12501

Group type: COMPARATOR
Intervention: HIV-negative individuals
Number of subjects: 12501

Group type: EXPERIMENTAL
Intervention: Overall adult deaths
Number of subjects: 12501

Group type: EXPERIMENTAL
Intervention: Adults aged 20-29 years
Number of subjects: 12501

Group type: EXPERIMENTAL
Intervention: HIV-positive deaths
Number of subjects: 12501

Group type: EXPERIMENTAL
Intervention: AIDS-related deaths
Number of subjects: 12501

Group type: EXPERIMENTAL
Intervention: Perception of HIV-related deaths
Number of subjects: 12501
Study: 8565795

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with opioid receptor antagonists naltrexone and nalmefene
Number of subjects: 0
Study: 2233917

Group type: EXPERIMENTAL
Intervention: Corticosteroids (40 mg of prednisone twice daily)
Number of subjects: 333

Group type: COMPARATOR
Intervention: No additional therapy (Control)
Number of subjects: 333
Study: 652481

Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at eleven azimuth positions (experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at ten angles of elevation (experiment 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at a single azimuth position before another (experiment 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seven vertical lines permutated randomly in experiments 1 and 2
Number of subjects: 0
Study: 31123852

Group type: EXPERIMENTAL
Intervention: Kidney-sparing surgery for low-grade UTUC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radical nephroureterectomy with bladder cuff excision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-operative bladder instillation of chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ureteroscopic management of low-grade and non-invasive UTUC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lymphadenectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platin-based chemotherapy for invasive UTUC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bacillus Calmette-Guérin (BCG) and mitomycin C
Number of subjects: 0
Study: 28394302

Group type: EXPERIMENTAL
Intervention: Pre-operative enteral nutrition (pre-EN) through a nasal-jejunum feeding tube
Number of subjects: 68

Group type: COMPARATOR
Intervention: Parenteral nutrition (PN)
Number of subjects: 68
Study: 25757214

Group type: EXPERIMENTAL
Intervention: Serial immune function testing (ImmuKnow assay)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 202
Study: 25224665

Group type: EXPERIMENTAL
Intervention: docetaxel-based chemotherapy + zoledronic acid (ZA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: docetaxel-based chemotherapy + placebo
Number of subjects: 105
Study: 22583028

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Education intervention plus incentive
Number of subjects: 121
Study: 20664163

Group type: EXPERIMENTAL
Intervention: Cooling shirt (mild cooling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ice vest (strong cooling)
Number of subjects: 0
Study: 17442125

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (CBT) for PTSD, conducted over a 5-week period (10 sessions)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (CBT) for PTSD
Number of subjects: 96

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 96
Study: 16450851

Group type: EXPERIMENTAL
Intervention: New experimental treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study: 12466029

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tyrosine/phenylalanine depletion (TPD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Balanced control condition (B)
Number of subjects: 13
Study: 9280026

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia
Number of subjects: 54

Group type: COMPARATOR
Intervention: Continuous epidural analgesia
Number of subjects: 54
Study: 8435991

Group type: EXPERIMENTAL
Intervention: Intensive dietary and exercise education
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard treatment given by community health centres (conventionally treated group)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Combined group with declining fasting blood glucose (n = 39)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Combined group with no change or increase in blood glucose level (n = 44)
Number of subjects: 83
Study: 3534631

Group type: EXPERIMENTAL
Intervention: Indenolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orciprenaline test
Number of subjects: 0
Study: 28905166

Group type: EXPERIMENTAL
Intervention: Self-help treatment including three motivational telephone interviews and a cognitive-behavioral self-help workbook
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Self-help treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 62
Study: 26555944

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 23893066

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) component of the depression prevention program 'Op Volle Kracht' (OVK), 8 lessons
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) component of OVK
Number of subjects: 102
Study: 22074913

Group type: EXPERIMENTAL
Intervention: Double-row technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: Suture-bridge technique
Number of subjects: 52
Study: 20440520

Group type: EXPERIMENTAL
Intervention: Cyclo + mtx (cyclosporin at 7.5 mg/kg/day for 6 weeks, then 4 mg/kg/day + methotrexate at 5 mg/kg/week for 1 year)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (standard insulin therapy)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Cyclo + mtx
Number of subjects: 17
Study: 17563342

Group type: EXPERIMENTAL
Intervention: HiMF training (HiMFT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: LoMF training (LoMFT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: HiMF control
Number of subjects: 55

Group type: COMPARATOR
Intervention: LoMF control
Number of subjects: 55
Study: 16249142

Group type: EXPERIMENTAL
Intervention: Narrowband blue light treatment (8 sessions of 10- or 20-minute treatments over 4 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Narrowband blue light treatment
Number of subjects: 30
Study: 12177624

Group type: EXPERIMENTAL
Intervention: T‐tube removal with contemporary placement of a counter‐drain under fluoroscopic guidance (group 1)
Number of subjects: 145

Group type: COMPARATOR
Intervention: T‐tube removal without counter‐drain (group 2)
Number of subjects: 145
Study: 10190617

Group type: EXPERIMENTAL
Intervention: Simple ganglion aspiration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspiration and multiple puncture
Number of subjects: 0
Study: 8524722

Group type: EXPERIMENTAL
Intervention: Community organization promotional activities (including physician reminders, wallet cards, newspaper ads)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Physician office staff encouragement
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Display board
Number of subjects: 2

Group type: COMPARATOR
Intervention: Promotional activities
Number of subjects: 2
Study: 1959800

Group type: EXPERIMENTAL
Intervention: Antithrombin III concentrate administration during surgery
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 6115807

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg, taken twice a day
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo, taken twice a day
Number of subjects: 168
Study: 30819464

Group type: EXPERIMENTAL
Intervention: Implementation Planning
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Role Play
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Participant Modeling
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Raising Awareness
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Motivational Consulting
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Implementation supports (overall)
Number of subjects: 14
Study: 28950351

Group type: EXPERIMENTAL
Intervention: CPB (carboplatin, paclitaxel, and bevacizumab)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: CPB plus cixutumumab 6 mg/kg i.v. weekly
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (historical controls)
Number of subjects: 153
Study: 26528705

Group type: EXPERIMENTAL
Intervention: Topotecan plus Cyclophosphamide
Number of subjects: 21
Study: 24667090

Group type: EXPERIMENTAL
Intervention: Nutrition-education program
Number of subjects: 1143
Study: 23139763

Group type: EXPERIMENTAL
Intervention: -110°C whole body cryotherapy (WBC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 8°C cold water immersion (CWI)
Number of subjects: 20
Study: 19337788

Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group with matching ethnic composition
Number of subjects: 92
Study: 17473847

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 3408

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 3408

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 3408

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 3408
Study: 15717138

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Losartan-placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Acute TD-GTN 20 mg
Number of subjects: 15
Study: 11443170

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (rhGH only)
Number of subjects: 18
Study: 10052878

Group type: EXPERIMENTAL
Intervention: Immobilization of the legs with an alpha-cradle system (Group B)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Immobilization at the pelvis level with an alpha-cradle system (Group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Previously investigated non-immobilized patients
Number of subjects: 52
Study: 7976150

Group type: EXPERIMENTAL
Intervention: Logistic regression models based on the APACHE II-system
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Inclusion of the TISS score
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Statistical models
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 952
Study: 2505641

Group type: EXPERIMENTAL
Intervention: Central venous pressure monitoring catheter (Group I)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Conventional pulmonary artery catheter (Group II)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Mixed venous oxygen saturation measuring PA catheter (Group III)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Conventional PA catheter (Group IV)
Number of subjects: 226

Group type: COMPARATOR
Intervention: SvO2 measuring PA catheter (Group V)
Number of subjects: 226
Study: 45573

Group type: EXPERIMENTAL
Intervention: Adding bicarbonate or Lactobacilli to feeds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bottle-fed infants without intervention
Number of subjects: 0
Study: 31286744

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 0
Study: 28720147

Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 26055927

Group type: EXPERIMENTAL
Intervention: Oral vancomycin 125mg every 6 hours for 10 days
Number of subjects: 15
Study: 23764999

Group type: EXPERIMENTAL
Intervention: Ambient visual information available during haptic scene exploration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blindfolded during haptic scene exploration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Geometric information about a surrounding (virtual) room
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambient visual information in early stages of the task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Novel environment (Experiment 3)
Number of subjects: 0
Study: 22282729

Group type: EXPERIMENTAL
Intervention: GBR + BS group (bone substitute plus a resorbable barrier)
Number of subjects: 80

Group type: COMPARATOR
Intervention: GBR group (resorbable barrier alone)
Number of subjects: 80
Study: 19239555

Group type: EXPERIMENTAL
Intervention: 0.75% adenosine lotion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 30
Study: 16317012

Group type: EXPERIMENTAL
Intervention: Dalteparin (5000 IU)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study: 14585873

Group type: EXPERIMENTAL
Intervention: Individual dose of rFSH (100-250 IU/day)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Standard dose of rFSH (150 IU/day)
Number of subjects: 267
Study: 10992823

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 30
Study: 8840821

Group type: EXPERIMENTAL
Intervention: PGWB
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PGWB-R
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PGWB and PGWB-R
Number of subjects: 60

Group type: COMPARATOR
Intervention: GSRS
Number of subjects: 60
Study: 1575558

Group type: EXPERIMENTAL
Intervention: Nutrient enriched 'post‐discharge' milk formula
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard term formula
Number of subjects: 32
Study: 2857910

Group type: EXPERIMENTAL
Intervention: Povidone-iodine 2% (50 ml instilled before catheter removal)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (catheter removed after urethral catheterisation)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Povidone-iodine intervention introduction
Number of subjects: 78
Study: 30805708

Group type: EXPERIMENTAL
Intervention: Cement augmentation of PHILOS screws (augmented group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: PHILOS screws without cement augmentation (control group)
Number of subjects: 67
Study: 29596869

Group type: EXPERIMENTAL
Intervention: Active training group (approach-avoidance training for unhealthy food cues)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sham training group (received sham training for both picture types)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Active training group
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sham training group
Number of subjects: 189
Study: 26284453

Group type: EXPERIMENTAL
Intervention: Sedentary-intervention (SIT, n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-intervention control (CON, n = 8)
Number of subjects: 16
Study: 25249560

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire (SAQ)
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: Changes in SAQ angina frequency scores from day 1 to week 8
Number of subjects: 917
Study: 23095223

Group type: EXPERIMENTAL
Intervention: Educational module training for nurse aide students
Number of subjects: 0
Study: 20977033

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic cognitive‐behavioral program including exposure technique (n = 28)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic cognitive‐behavioral program with communication skills training (n = 25)
Number of subjects: 53
Study: 18405161

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 22